Literature DB >> 20507592

The effect of a pedometer-based community walking intervention "Walking for Wellbeing in the West" on physical activity levels and health outcomes: a 12-week randomized controlled trial.

Graham Baker1, Stuart R Gray, Annemarie Wright, Claire Fitzsimons, Myra Nimmo, Ruth Lowry, Nanette Mutrie.   

Abstract

Entities:  

Year:  2010        PMID: 20507592      PMCID: PMC2893448          DOI: 10.1186/1479-5868-7-51

Source DB:  PubMed          Journal:  Int J Behav Nutr Phys Act        ISSN: 1479-5868            Impact factor:   6.457


× No keyword cloud information.

Correction

Since publication of our article[1] we have found some imputation errors in the main text and Table Four (Table 1) and Table Five (Table 2) corresponding to the 12-week results. The corrections are as follows:
Table 1

Descriptive statistics for age, pedometer step-counts and health related outcomes at baseline and week 12 for intervention and control group.

Intervention Group (n = 39)Control Group (n = 40)
BaselineWeek 12BaselineWeek 12

Age (years)47.3 (9.3)a51.2 (7.9)a

Steps/day6802 (3212)9977 (4669)6924 (3201)7078 (2911)

PANAS positive31.2 (6.7)33.5 (7.4)31.7 (6.9)31.3 (7.6)

PANAS negative20.1 (7.2)19.1 (6.9)20.2 (8.1)18.8 (7.5)

EQ-5D tariff0.88 (0.12)0.89 (0.11)0.87 (0.12)0.89 (0.12)

EQ VAS65.4 (18.3)69.5 (17.8)69.8 (19.7)70.7 (18.6)

Height (m)b1.66 (0.08)a1.64 (0.08)a

Body Mass (kg)b78.9 (15.6)79.1 (15.2)79.5 (18.1)79.5 (17.8)

BMI (kg/m2)b28.5 (4.8)28.6 (4.8)29.4 (6.3)29.5 (6.2)

Waist circumference (cm)b89.5 (12.6)89.8 (12.7)90.4 (14.6)90.9 (15.6)

Hip circumference (cm)b108.9 (8.8)108.5 (9.7)110.1 (12.4)110.2 (11.8)

Waist:Hip Ratiob0.82 (0.08)0.83 (0.08)0.82 (0.09)0.82 (0.09)

% body fatb30.7 (4.4)31.2 (4.9)31.8 (5.6)32.5 (6.3)

Systolic blood pressure (mm Hg)b118.2 (17.9)119.2 (17.0)119.9 (15.9)121.4 (15.1)

Diastolic blood pressure (mm Hg)b75.1 (11.4)76.3 (12.2)75.5 (11.8)78.2 (11.8)

Heart Rate (beats.min-1)c68.6 (7.2)69.5 (8.3)67.9 (8.6)68.9 (9.0)

Total Cholesterol (mmol.l-1)c5.4 (1.3)5.4 (1.2)5.5 (1.1)5.5 (1.0)

HDL (mmol-1)c1.3 (0.3)1.3 (0.3)1.4 (0.4)1.4 (0.4)

Chol:HDL Ratioc4.2 (1.1)4.2 (1.1)4.1 (1.2)4.1 (1.3)

Values are mean (M) and standard deviation (SD).

a not measured at week 12

b anthropometric measures: (n = 37) for intervention group, (n = 39) for control group

c blood measures: (n = 32) for intervention group, (n = 34) for control group

Note: there were no significant differences between the intervention and control group for any variable at baseline

Table 2

Descriptive statistics for IPAQ variables at baseline and week 12.

Intervention Group (n = 39)Control Group (n = 40)
BaselineWeek 12BaselineWeek 12

Work-related PA
Vigorous PA0 (1080)0 (1800)0 (720)0 (540)
Moderate PA0 (1500)0 (900)0 (1500)0 (600)
Walking0 (1620)0 (2520)0 (1350)0 (1650)
Total0 (3000)30 (4680)0 (2550)0 (2730)
Transportation PA
Bicycling0 (0)0 (0)0 (40)0 (40)
Walking105 (1680)140 (900)80 (1680)70 (1680)
Total105 (1680)140 (900)80 (1720)70 (1720)
Housework PA
Vigorous outside home0 (840)0 (840)0 (750)0 (360)
Moderate outside home0 (2100)0 (1680)0 (1260)0 (840)
Moderate inside home210 (2100)150 (840)180 (1680)120 (1680)
Total360 (4200)300 (2520)255 (2640)202.5 (2520)
Leisure-time PA
Walking40 (840)100 (840)35 (600)16.25 (840)
Vigorous PA0 (180)0 (120)0 (120)0 (600)
Moderate PA0 (360)0 (60)0 (180)0 (180)
Total60 (840)120 (840)60 (600)60 (840)
Combined Domains
Total Walking225 (3360)290 (2850)167.5 (1740)155 (1925)
Total Moderate PA420 (4380)405 (2760)360 (2640)262.5 (2590)
Total Vigorous PA0 (1080)0 (1800)0 (720)0 (600)
Total PA690 (6300)840 (5415)640 (4300)577.5 (4270)
Time Spent Sitting
Weekday1500 (3750)1200 (3900)1500 (3450)1500 (2850)
Weekend480 (1320)360 (1200)600 (1200)600 (1320)
Total1980 (4650)1680 (5100)2130 (4170)2100 (3630)

Values are median (Mdn) and range (r).

Descriptive statistics for age, pedometer step-counts and health related outcomes at baseline and week 12 for intervention and control group. Values are mean (M) and standard deviation (SD). a not measured at week 12 b anthropometric measures: (n = 37) for intervention group, (n = 39) for control group c blood measures: (n = 32) for intervention group, (n = 34) for control group Note: there were no significant differences between the intervention and control group for any variable at baseline Descriptive statistics for IPAQ variables at baseline and week 12. Values are median (Mdn) and range (r). In the results section of the manuscript the median differences presented in the text for the Wilcoxon's signed-rank tests in the intervention group should be, 1. Leisure minutes walked: "60" not "100" 2. Weekday sitting: "- 300" not "1200" 3. Weekend sitting: "- 120" not "360" 4. Total sitting: "- 300" not "1680" In the results section of the manuscript the median difference presented for the Mann Whitney U test at week 12 between groups should be, 1. Total minutes walked: "135" not "57.5" As a consequence of the amendment to the median leisure minutes walked in the intervention group the following sentence from the discussion should be corrected as follows: Original Sentence "The increase observed in the step-count data was supported by the self-reported results of the IPAQ; a significant increase in reported minutes of leisure time walking was found in the intervention group (median increase of 100 minutes per/week)." Amended Sentence "The increase observed in the step-count data was supported by the self-reported results of the IPAQ; a significant increase in reported minutes of leisure time walking was found in the intervention group (median increase of 60 minutes per/week)."
  1 in total

1.  The effect of a pedometer-based community walking intervention "Walking for Wellbeing in the West" on physical activity levels and health outcomes: a 12-week randomized controlled trial.

Authors:  Graham Baker; Stuart R Gray; Annemarie Wright; Claire Fitzsimons; Myra Nimmo; Ruth Lowry; Nanette Mutrie
Journal:  Int J Behav Nutr Phys Act       Date:  2008-09-05       Impact factor: 6.457

  1 in total
  14 in total

1.  Supporting South Asian Taxi Drivers to Exercise through Pedometers (SSTEP) to decrease cardiovascular disease risk.

Authors:  Francesca Gany; Pavan Gill; Raymond Baser; Jennifer Leng
Journal:  J Urban Health       Date:  2014-06       Impact factor: 3.671

2.  The influence of the local neighbourhood environment on walking levels during the Walking for Wellbeing in the West pedometer-based community intervention.

Authors:  L B Robertson; C Ward Thompson; P Aspinall; C Millington; C McAdam; N Mutrie
Journal:  J Environ Public Health       Date:  2012-07-29

3.  Cardiometabolic results from an armband-based weight loss trial.

Authors:  John C Sieverdes; Xuemei Sui; Gregory A Hand; Vaughn W Barry; Sara Wilcox; Rebecca A Meriwether; James W Hardin; Amanda C McClain; Steven N Blair
Journal:  Diabetes Metab Syndr Obes       Date:  2011-05-30       Impact factor: 3.168

4.  Empowering sedentary adults to reduce sedentary behavior and increase physical activity levels and energy expenditure: a pilot study.

Authors:  Faisal A Barwais; Thomas F Cuddihy
Journal:  Int J Environ Res Public Health       Date:  2015-01-05       Impact factor: 3.390

Review 5.  A comparison of the effectiveness of physical activity and sedentary behaviour interventions in reducing sedentary time in adults: a systematic review and meta-analysis of controlled trials.

Authors:  S A Prince; T J Saunders; K Gresty; R D Reid
Journal:  Obes Rev       Date:  2014-08-11       Impact factor: 9.213

Review 6.  Effects of Exercise on the Resting Heart Rate: A Systematic Review and Meta-Analysis of Interventional Studies.

Authors:  Anne Kerstin Reimers; Guido Knapp; Carl-Detlev Reimers
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

7.  Is wearing a pedometer associated with higher physical activity among adolescents?

Authors:  Vanda Ho; Rebecca K Simmons; Charlotte L Ridgway; Esther M F van Sluijs; Diane J Bamber; Ian M Goodyer; Valerie J Dunn; Ulf Ekelund; Kirsten Corder
Journal:  Prev Med       Date:  2013-02-04       Impact factor: 4.018

8.  Effectiveness of a walking programme to support adults with intellectual disabilities to increase physical activity: walk well cluster-randomised controlled trial.

Authors:  Craig A Melville; Fiona Mitchell; Kirsten Stalker; Lynsay Matthews; Alex McConnachie; Heather M Murray; Chris Melling; Nanette Mutrie
Journal:  Int J Behav Nutr Phys Act       Date:  2015-09-29       Impact factor: 6.457

9.  Walk Well: a randomised controlled trial of a walking intervention for adults with intellectual disabilities: study protocol.

Authors:  Fiona Mitchell; Craig Melville; Kirsten Stalker; Lynsay Matthews; Alex McConnachie; Heather Murray; Andrew Walker; Nanette Mutrie
Journal:  BMC Public Health       Date:  2013-07-01       Impact factor: 3.295

10.  Process evaluation of the Walk Well study: a cluster-randomised controlled trial of a community based walking programme for adults with intellectual disabilities.

Authors:  Lynsay Matthews; Fiona Mitchell; Kirsten Stalker; Alex McConnachie; Heather Murray; Chris Melling; Nanette Mutrie; Craig Melville
Journal:  BMC Public Health       Date:  2016-07-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.